The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, to treat the “major global health challenge” of obesity.
365Daily.net
365Daily.net
The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, to treat the “major global health challenge” of obesity.
